THE LOW-FODMAP DIET IN IRRITABLE BOWEL SYNDROME: EFFECTIVENESS, LIMITATIONS, AND PRACTICAL IMPLICATIONS - A NARRATIVE REVIEW
DOI:
https://doi.org/10.31435/ijitss.3(51).2026.5919Keywords:
Irritable Bowel Syndrome (IBS); low-FODMAP Diet; Functional Gastrointestinal Disorders; Dietary Intervention; Nutrition TherapyAbstract
Introduction: Irritable bowel syndrome is characterized by symptoms such as abdominal pain associated with defecation and changes in stool frequency and/or consistency. In recent years, the low-FODMAP diet has become one of the most commonly used dietary interventions.
Aim of the study: The aim of this study was to assess the effectiveness of the low-FODMAP diet and to identify its limitations and consistency with current guidelines.
Methods: A narrative review of the literature was conducted, including 31 publications from 2012–2026, such as original research articles, randomized controlled trials, systematic reviews, meta-analyses, and current clinical guidelines on the diagnosis and treatment of IBS. PubMed and Google Scholar databases were searched using predefined inclusion and exclusion criteria.
Main findings: The results of the analyzed studies indicate that the low-FODMAP diet may reduce IBS symptoms such as bloating, abdominal pain, and intestinal discomfort. However, no clear superiority over other dietary strategies has been demonstrated. Clinical response varies and may depend on the patient’s gut microbiota. Data on the use of the low-FODMAP diet in the pediatric population and other special clinical groups are limited and do not allow definitive conclusions to be drawn.
Conclusions: The low-FODMAP diet is an effective therapeutic option in selected patients with IBS; however, it should be implemented in stages, including elimination, reintroduction, and personalization phases. Supervision by a dietitian and individual adjustment of recommendations to the patient’s needs are recommended. Further studies are needed to assess the long-term effects of the diet and predictors of clinical response.
References
Alrasheedi, A. A., et al. (2026). The effect of low-FODMAP diet on patients with irritable bowel syndrome. Scientific Reports. https://doi.org/10.1038/s41598-025-01163-3
Bellini, M., Tonarelli, S., Nagy, A. G., Pancetti, A., Costa, F., Ricchiuti, A., de Bortoli, N., Mosca, M., Marchi, S., & Rossi, A. (2020). Low FODMAP diet: Evidence, doubts, and hopes. Nutrients, 12(1), 148. https://doi.org/10.3390/nu12010148
Bogdanowska-Charkiewicz, D., Górski, P., Jurkowska, G., Środa, R., Świdnicka-Siergiejko, A., Dąbrowski, A., & Daniluk, J. (2026). Effectiveness of the low FODMAP diet in patients with irritable bowel syndrome and small intestine bacterial overgrowth syndrome. Frontiers in Nutrition, 13, 1725524. https://doi.org/10.3389/fnut.2026.1725524
Bogdanowska-Charkiewicz, D., Malinowska, U., & Daniluk, J. (2026). An umbrella review of meta-analyses on the low-FODMAP diet in IBS. Frontiers in Nutrition, 12, 1714281. https://doi.org/10.3389/fnut.2025.1714281
Böhn, L., Störsrud, S., Liljebo, T., Collin, L., Lindfors, P., Törnblom, H., & Simrén, M. (2015). Diet low in FODMAPs reduces symptoms of irritable bowel syndrome as well as traditional dietary advice: A randomized controlled trial. Gastroenterology, 149(6), 1399–1407.e2. https://doi.org/10.1053/j.gastro.2015.07.054
Brown, S. C., Whelan, K., Gearry, R. B., & Day, A. S. (2019). Low FODMAP diet in children and adolescents with functional bowel disorder: A clinical case note review. JGH Open: An Open Access Journal of Gastroenterology and Hepatology, 4(2), 153–159. https://doi.org/10.1002/jgh3.12231
Choi, Y., Youn, Y. H., Kang, S. J., Shin, J. E., Cho, Y. S., Jung, Y. S., Shin, S. Y., Huh, C. W., Lee, Y. J., Koo, H. S., Nam, K., Lee, H. S., Kim, D. H., Park, Y. H., Kim, M. C., Song, H. Y., Yoon, S.-H., Lee, S. Y., Choi, M., … Sung, I.-K. (2025). 2025 Seoul consensus on clinical practice guidelines for irritable bowel syndrome. Journal of Neurogastroenterology and Motility, 31(2), 133–169. https://doi.org/10.5056/jnm25007
Chumpitazi, B. P., Cope, J. L., Hollister, E. B., Tsai, C. M., McMeans, A. R., Luna, R. A., Versalovic, J., & Shulman, R. J. (2015). Randomised clinical trial: Gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with irritable bowel syndrome. Alimentary Pharmacology & Therapeutics, 42(4), 418–427. https://doi.org/10.1111/apt.13286
Cristofori, F., Castellaneta, S., Dargenio, C., Paulucci, L., Lagrasta, G., Barone, M., Francavilla, R., & Dargenio, V. N. (2025). Unlocking the potential of the low FODMAP diet: Comprehensive insights into clinical efficacy, microbiome modulation, and beyond. Expert Review of Gastroenterology & Hepatology, 19(7), 767–787. https://doi.org/10.1080/17474124.2025.2519160
Dogan, G., Yavuz, S., Aslantas, H., Ozyurt, B. C., & Kasirga, E. (2020). Is low FODMAP diet effective in children with irritable bowel syndrome? Northern Clinics of Istanbul, 7(5), 433–437. https://doi.org/10.14744/nci.2020.40326
Espitia, O. L. P., Barrera-Mojica, M. C., Moya, P. S. C., Zuleta, M. A. G., & Mejía, A. C. (2026). Eficacia e implementación clínica de la dieta baja en FODMAP en el síndrome de intestino irritable: Revisión sistemática. Revista Colombiana de Gastroenterología, 41(1), 62–77. https://doi.org/10.22516/25007440.1386
Ezaby, S. A. E., Manzour, A. F., Eldeeb, M., Gendy, Y. G. E., Hamid, D. M. A., Ezaby, S. E., Manzour, A. F., Eldeeb, M., Gendy, Y. E., & Hamid, D. M. A. (2024). Effect of the low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAP) diet on control of pediatric irritable bowel syndrome and quality of life among a sample of Egyptian children: A randomized controlled clinical trial. Cureus, 16(5), e61017. https://doi.org/10.7759/cureus.61017
Halmos, E. P., Power, V. A., Shepherd, S. J., Gibson, P. R., & Muir, J. G. (2014). A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology, 146(1), 67–75.e5. https://doi.org/10.1053/j.gastro.2013.09.046
Harvie, R. M., Chisholm, A. W., Bisanz, J. E., Burton, J. P., Herbison, P., Schultz, K., & Schultz, M. (2017). Long-term irritable bowel syndrome symptom control with reintroduction of selected FODMAPs. World Journal of Gastroenterology, 23(25), 4632–4643. https://doi.org/10.3748/wjg.v23.i25.4632
Hill, P., Muir, J. G., & Gibson, P. R. (2017). Controversies and recent developments of the low-FODMAP diet. Gastroenterology & Hepatology, 13(1), 36–45.
Kuźmin, L., Kubiak, K., & Lange, E. (2025). Efficacy of a low-FODMAP diet on the severity of gastrointestinal symptoms and quality of life in the treatment of gastrointestinal disorders—A systematic review of randomized controlled trials. Nutrients, 17(12), 2045. https://doi.org/10.3390/nu17122045
Lacy, B. E., Pimentel, M., Brenner, D. M., Chey, W. D., Keefer, L. A., Long, M. D., & Moshiree, B. (2021). ACG clinical guideline: Management of irritable bowel syndrome. The American Journal of Gastroenterology, 116(1), 17–44. https://doi.org/10.14309/ajg.0000000000001036
Lucas Zapata, P., García Navarro, E., & Ribes Koninckx, C. (2024). The low-FODMAP diet. Anales de Pediatría (English Edition), 101(1), 36–45. https://doi.org/10.1016/j.anpede.2024.06.005
Magge, S., & Lembo, A. (2012). Low-FODMAP diet for treatment of irritable bowel syndrome. Gastroenterology & Hepatology, 8(11), 739–745.
Melgaard, D., Sørensen, J., Riis, J., Ovesen, T. S., Leutscher, P., Sørensen, S., Knudsen, J. K., Bundgaard-Nielsen, C., Ejstrup, J., Jensen, A.-M., Borre, M., & Krarup, A. L. (2022). Efficacy of FODMAP elimination and subsequent blinded placebo-controlled provocations in a randomised controlled study in patients with ulcerative colitis in remission and symptoms of irritable bowel syndrome: A feasibility study. Nutrients, 14(6), 1296. https://doi.org/10.3390/nu14061296
Narayana, V., McMeans, A. R., Levy, R. L., Shulman, R. J., & Chumpitazi, B. P. (2022). Children with functional abdominal pain disorders successfully decrease FODMAP food intake on a low FODMAP diet with modest improvements in nutritional intake and diet quality. Neurogastroenterology & Motility, 34(10), e14392. https://doi.org/10.1111/nmo.14392
Pensabene, L., Salvatore, S., Turco, R., Tarsitano, F., Concolino, D., Baldassarre, M. E., Borrelli, O., Thapar, N., Vandenplas, Y., Staiano, A., & Saps, M. (2019). Low FODMAPs diet for functional abdominal pain disorders in children: Critical review of current knowledge. Jornal de Pediatria, 95(6), 642–656. https://doi.org/10.1016/j.jped.2019.03.004
Raja, S., Teitelbaum, J. E., Pereira, K., Guli, K., & Schosheim, A. (2025). Efficacy of low FODMAP diet in pediatric patients with disorders of gut–brain interaction. JPGN Reports, 6(2), 75–79. https://doi.org/10.1002/jpr3.12157
Rhys-Jones, D., Varney, J. E., Muir, J. G., Gibson, P. R., & Halmos, E. P. (2022). Application of the FODMAP diet in a paediatric setting. Nutrients, 14(20), 4369. https://doi.org/10.3390/nu14204369
Russo, F., Riezzo, G., Orlando, A., Linsalata, M., D’Attoma, B., Prospero, L., Ignazzi, A., & Giannelli, G. (2022). A comparison of the low-FODMAPs diet and a Tritordeum-based diet on the gastrointestinal symptom profile of patients suffering from irritable bowel syndrome-diarrhea variant (IBS-D): A randomized controlled trial. Nutrients, 14(8), 1544. https://doi.org/10.3390/nu14081544
Sood, R., Foy, R., & Ford, A. C. (2017). Making a positive diagnosis of irritable bowel syndrome. The British Journal of General Practice, 67(665), 580–581. https://doi.org/10.3399/bjgp17X693857
Stróżyk, A., Horvath, A., Kozłowska-Jalowska, A., Muir, J., & Szajewska, H. (2026). Efficacy of a low-FODMAP diet in children with irritable bowel syndrome and functional abdominal pain–not otherwise specified: A randomized controlled trial with early termination. Frontiers in Pediatrics, 14, 1809053. https://doi.org/10.3389/fped.2026.1809053
Thomassen, R. A., Luque, V., Assa, A., Borrelli, O., Broekaert, I., Dolinsek, J., Martin-de-Carpi, J., Mas, E., Miele, E., Norsa, L., Ribes-Koninckx, C., Saccomani, M. D., Thomson, M., Tzivinikos, C., Verduci, E., Bronsky, J., Haiden, N., Köglmeier, J., de Koning, B., & Benninga, M. A. (2022). An ESPGHAN position paper on the use of low-FODMAP diet in pediatric gastroenterology. Journal of Pediatric Gastroenterology and Nutrition, 75(3), 356–368. https://doi.org/10.1097/MPG.0000000000003526
Turan, B., Bengi, G., Cehreli, R., Akpınar, H., & Soytürk, M. (2021). Clinical effectiveness of adding probiotics to a low FODMAP diet: Randomized double-blind placebo-controlled study. World Journal of Clinical Cases, 9(25), 7417–7432. https://doi.org/10.12998/wjcc.v9.i25.7417
Vasant, D. H., Paine, P. A., Black, C. J., Houghton, L. A., Everitt, H. A., Corsetti, M., Agrawal, A., Aziz, I., Farmer, A. D., Eugenicos, M. P., Moss-Morris, R., Yiannakou, Y., & Ford, A. C. (2021). British Society of Gastroenterology guidelines on the management of irritable bowel syndrome. Gut, 70(7), 1214–1240. https://doi.org/10.1136/gutjnl-2021-324598
Zhang, H., & Su, Q. (2025). Low-FODMAP diet for irritable bowel syndrome: Insights from microbiome. Nutrients, 17(3), 544. https://doi.org/10.3390/nu17030544
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Julia Gatniejewska, Martyna Sienicka, Paulina Prudzic, Weronika Winiarska, Wiktoria Bełcikowska-Skowron, Aleksandra Siegmund, Marzena Chrapczyńska, Agnieszka Filarecka, Piotr Przybyszewski, Emilia Przybyszewska
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.
How to Cite
